Scaling innovation to tackle Europe’s growing mental health crisis
NR Times recently spoke to Dr Tamara Werner-Kiechle, Therapeutic Area [...]
The challenges facing the UK neurorehabilitation charity sector
By Natalie Mackenzie, Director, BIS Services
Would you take the dementia test as part of your financial planning journey?
From an estate planning perspective, the prediction of a future [...]
“How can this be happening in this day and age?” – SCI survivor calls for gender equity in healthcare
After a humiliating incident at her local NHS trust, Dani Czernuszka-Watts, joined forces with the Spinal Injuries Association (SIA) to campaign for gender equity in healthcare.
Subscribe to read Dani's story and find out more about a new campaign aiming to bring change and equity in women’s healthcare.
Understanding cauda equina syndrome and your legal options
Article by Eddie Jones, Partner in Medical Negligence at JMW [...]
How the role of the mentor helps to shape best practice in case management
By Laura Porter, Professional Mentor at ILS I qualified as [...]
A risky strategy for spinal cord patients?
Ruth Hunt, a journalist and columnist who lives with spinal cord injury, on what she believes is a concerning reduction in access to in-person appointments.
In-person monitoring appointments for long-term patients with a spinal cord injury (SCI) have now, in many cases, been replaced with remote calls, either by phone or video; meaning many of those with substantial needs are not getting a regular face to face appointment with their spinal team putting them at risk of harm. Using remote methods, such as phone or video calls for appointments with doctors is something we have seen in primary care. But it hasn’t stopped there, such appointments have seeped into secondary services, such as spinal cord injury centres (SCIC). This has caused alarm as the research regarding remote appointments in primary care reveals serious safety concerns for some patients. Could this be the case for those using secondary services like those living with SCI?
Looking into the future of a world transformed by Neurotechnology
"The recent advancements in neurotechnology will significantly transform various aspects of society, offering profound implications for healthcare, communication, and human capabilities" - Alexandrea Day, CEO of MetaBrain Labs
Opinion: The tech breakthrough that could revolutionise stroke care
Expert analysis on the role of live stroke registries in improving pathway management.
Expert analysis: New dimensions in our understanding of MS
By Norman Putzki (MD PhD), global head development neuroscience and gene therapy at Novartis.
Over the last 30 years, remarkable progress has been made in the advancement of treating multiple sclerosis (MS), a potentially disabling disease that is most likely a consequence of complex autoimmune dysfunctions in the periphery ultimately leading to demyelination in the central nervous system (CNS).
Since 1993, a series of insights has led to greater understanding of the biological mechanisms and triggers driving the inflammatory attacks on the CNS.
These translational insights have also driven the development of newer and more effective treatments in MS.
